These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 2744882)

  • 21. A serum-free medium for the Courtenay-Mills soft agar assay.
    Wilks DP; West CM
    Int J Cell Cloning; 1991 Nov; 9(6):559-69. PubMed ID: 1770230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A simple method of delayed processing of tumor tissue in a soft agar clonogenic assay.
    Krischke W; Hartmann R; Schneider M; Schönenberger H
    J Cancer Res Clin Oncol; 1988; 114(2):170-6. PubMed ID: 3350850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation sensitivity of endometrial carcinoma in vitro.
    Rantanen V; Grénman S; Kulmala J; Salmi T; Grénman R
    Gynecol Oncol; 1992 Mar; 44(3):217-22. PubMed ID: 1541432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status.
    Reid P; Wilson P; Li Y; Marcu LG; Staudacher AH; Brown MP; Bezak E
    PLoS One; 2017; 12(10):e0186186. PubMed ID: 29028842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity of bleomycin and external radiation in squamous cell cancer cell lines of head and neck.
    Jääskelä-Saari HA; Kairemo KJ; Jekunen AP; Pekkola-Heino K; Kulmala J; Ramsay HA; Grenman R
    Cancer Detect Prev; 1996; 20(4):279-84. PubMed ID: 8818387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tumor cell viability and inoculum density on growth parameters in the human tumor, soft-agar clonogenic assay.
    Page RH; Tilchen EJ; Davis HL
    Cancer Res; 1988 Jul; 48(14):3944-8. PubMed ID: 3383190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.
    Rantanen V; Grénman S; Kulmala J; Grénman R
    J Cancer Res Clin Oncol; 1995; 121(4):230-4. PubMed ID: 7751322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved plating efficiencies for human tumors cloned in capillary tubes versus Petri dishes.
    Von Hoff DD; Forseth BJ; Huong M; Buchok JB; Lathan B
    Cancer Res; 1986 Aug; 46(8):4012-7. PubMed ID: 3731071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
    Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
    Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel combined with fractionated radiation in vitro: a study with vulvar squamous cell carcinoma cell lines.
    Raitanen M; Rantanen V; Kulmala J; Pulkkinen J; Klemi P; Grénman S; Grénman R
    Int J Cancer; 2002 Feb; 97(6):853-7. PubMed ID: 11857367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clonogenic assay: adherent cells.
    Rafehi H; Orlowski C; Georgiadis GT; Ververis K; El-Osta A; Karagiannis TC
    J Vis Exp; 2011 Mar; (49):. PubMed ID: 21445039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic interaction between cisplatin and tamoxifen delays the emergence of cisplatin resistance in head and neck cancer cell lines.
    Nakata B; Albright KD; Barton RM; Howell SB; Los G
    Cancer Chemother Pharmacol; 1995; 35(6):511-8. PubMed ID: 7882460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetry of irradiation models. The 96-well clonogenic assay for testing radiosensitivity of cell lines.
    Kulmala J; Rantanen V; Pekkola-Heino K; Tuominen J; Grénman R
    Acta Oncol; 1995; 34(1):105-9. PubMed ID: 7865224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of head and neck squamous cell carcinoma invasiveness by the electrical resistance breakdown assay.
    Mandic R; Ludwig T; Oberleithner H; Werner JA
    Clin Exp Metastasis; 2004; 21(8):699-704. PubMed ID: 16035614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spheroid control of malignant glioma cell lines after fractionated irradiation: relation to the surviving fractions at 2 Gy and colony forming efficiencies in a soft agar clonogenic assay.
    Stuschke M; Budach V; Kalff RL; Sack H; Bamberg M; Reinhardt V; Feldmann HJ
    Radiother Oncol; 1993 Jun; 27(3):245-51. PubMed ID: 8210460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of clonogenic cell fraction in primary cultures derived from human squamous cell carcinomas.
    Geara F; Girinski TA; Chavaudra N; Cosset JM; Dubray B; Brock WA; Malaise EP
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):661-5. PubMed ID: 1869460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supra-additive effect with concurrent paclitaxel and cisplatin in vulvar squamous cell carcinoma in vitro.
    Raitanen M; Rantanen V; Kulmala J; Helenius H; Grénman R; Grénman S
    Int J Cancer; 2002 Jul; 100(2):238-43. PubMed ID: 12115575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
    Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
    Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Technical problems with soft agar colony formation assays for in vitro chemotherapy sensitivity testing of human solid tumors: Mayo Clinic experience.
    Lieber MM
    Recent Results Cancer Res; 1984; 94():51-5. PubMed ID: 6494589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity.
    Pekkola-Heino K; Kulmala J; Klemi P; Lakkala T; Aitasalo K; Joensuu H; Grenman R
    J Cancer Res Clin Oncol; 1991; 117(6):597-602. PubMed ID: 1744166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.